-+ 0.00%
-+ 0.00%
-+ 0.00%
Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA
Share
Listen to the news

• Company gains further clarity on the additional information required to advance its PMA review

• FDA did not request an additional clinical trial following its 100-day review of the PMA application

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending